相似文献
1
Gene therapy.
Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):12744-6. doi: 10.1073/pnas.94.24.12744.
2
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics.
Nat Med. 2001 Jan;7(1):33-40. doi: 10.1038/83324.
3
Viruses in therapy--royal road or dead end?
Virus Res. 2003 Apr;92(2):219-21. doi: 10.1016/s0168-1702(02)00355-6.
4
Gene transfer by viral vectors for gene therapy.
J Mol Med (Berl). 1995 Mar;73(3):103-5. doi: 10.1007/BF00198236.
5
Viral Vectors for Gene Therapy: Current State and Clinical Perspectives.
Biochemistry (Mosc). 2016 Jul;81(7):700-8. doi: 10.1134/S0006297916070063.
6
Versatility of gene therapy vectors through viruses.
Expert Opin Biol Ther. 2005 May;5(5):639-62. doi: 10.1517/14712598.5.5.639.
7
Getting oncolytic virus therapies off the ground.
Cancer Cell. 2003 Jul;4(1):7-11. doi: 10.1016/s1535-6108(03)00170-3.
8
Nonviral strategies for gene therapy.
Sci Am. 1997 Jun;276(6):102-6. doi: 10.1038/scientificamerican0697-102.
9
Engineering targeted viral vectors for gene therapy.
Nat Rev Genet. 2007 Aug;8(8):573-87. doi: 10.1038/nrg2141. Epub 2007 Jul 3.
10
Lipoplexes Could be Alternative to Viral Vectors in Gene Therapy.
Am J Med Genet A. 2020 Jul;182(7):1548-1549. doi: 10.1002/ajmg.a.61241.
引用本文的文献
1
Neurosurgical gene therapy for central nervous system diseases.
Neurotherapeutics. 2024 Jul;21(4):e00434. doi: 10.1016/j.neurot.2024.e00434. Epub 2024 Aug 26.
2
microRNA-181a silencing by antisense oligonucleotides delivered by virus-like particles.
J Mater Chem B. 2023 Jan 25;11(4):816-825. doi: 10.1039/d2tb02199d.
3
Gene Therapy Approach with an Emphasis on Growth Factors: Theoretical and Clinical Outcomes in Neurodegenerative Diseases.
Mol Neurobiol. 2022 Jan;59(1):191-233. doi: 10.1007/s12035-021-02555-y. Epub 2021 Oct 15.
4
Gene Therapy Tools for Brain Diseases.
Front Pharmacol. 2019 Jul 1;10:724. doi: 10.3389/fphar.2019.00724. eCollection 2019.
5
Poly(ethylenimine) conjugated bioreducible dendrimer for efficient gene delivery.
J Control Release. 2015 Dec 28;220(Pt A):447-455. doi: 10.1016/j.jconrel.2015.11.005. Epub 2015 Nov 10.
6
Gene and cell therapy for muscle regeneration.
Curr Rev Musculoskelet Med. 2015 Jun;8(2):182-187. doi: 10.1007/s12178-015-9268-9.
7
Considerations for the treatment of infantile neuronal ceroid lipofuscinosis (infantile Batten disease).
J Child Neurol. 2013 Sep;28(9):1151-8. doi: 10.1177/0883073813495960.
8
Delivery systems for gene therapy.
Indian J Hum Genet. 2013 Jan;19(1):3-8. doi: 10.4103/0971-6866.112870.
9
Effects of moisture content on the storage stability of dried lipoplex formulations.
J Pharm Sci. 2009 Sep;98(9):3278-89. doi: 10.1002/jps.21846.
10
Rapid titration of adenoviral infectivity by flow cytometry in batch culture of infected HEK293 cells.
Cytotechnology. 2002 Jan;38(1-3):87-97. doi: 10.1023/A:1021106116887.
本文引用的文献
1
Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration.
Hum Gene Ther. 1997 Sep 1;8(13):1585-94. doi: 10.1089/hum.1997.8.13-1585.
2
Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration.
Gene Ther. 1997 Jun;4(6):517-23. doi: 10.1038/sj.gt.3300424.
3
Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors.
Nat Genet. 1997 Jul;16(3):270-6. doi: 10.1038/ng0797-270.
4
Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus.
Proc Natl Acad Sci U S A. 1997 May 27;94(11):5804-9. doi: 10.1073/pnas.94.11.5804.
5
Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver.
Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4686-91. doi: 10.1073/pnas.94.9.4686.
6
Recombinant adeno-associated virus for muscle directed gene therapy.
Nat Med. 1997 Mar;3(3):306-12. doi: 10.1038/nm0397-306.
7
Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery.
FEBS Lett. 1997 Jan 3;400(2):233-7. doi: 10.1016/s0014-5793(96)01397-x.
8
New cationic lipid formulations for gene transfer.
Pharm Res. 1996 Dec;13(12):1856-60. doi: 10.1023/a:1016041326636.
9
Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo.
J Virol. 1996 Dec;70(12):8944-60. doi: 10.1128/JVI.70.12.8944-8960.1996.
10
Effect of non-ionic surfactants on the formation of DNA/emulsion complexes and emulsion-mediated gene transfer.
Pharm Res. 1996 Nov;13(11):1642-6. doi: 10.1023/a:1016480421204.
Zotero 插件